State Street SPDR S&P Pharmaceuticals ETF (XPH)
NYSEARCA: XPH · Real-Time Price · USD
56.84
+0.02 (0.04%)
Feb 13, 2026, 4:00 PM EST - Market closed

XPH Holdings Information

XPH is an equity ETF with a total of 59 individual holdings. The top holdings are Viatris stock at 2.55%, MBX Biosciences at 2.47%, Definium Therapeutics at 2.46%, Edgewise Therapeutics at 2.40%, and Nektar Therapeutics at 2.31%.

Total Holdings
59
Top 10 Percentage
23.49%
Asset Class
Equity
ETF Category
Health
Assets
313.09M
PE Ratio
16.73

Breakdown by Sector

Top 25 Holdings

No.SymbolName WeightShares
1VTRSViatris Inc.2.55%500,004
2MBXMBX Biosciences, Inc.2.47%201,251
3DFTXDefinium Therapeutics, Inc.2.46%468,501
4EWTXEdgewise Therapeutics, Inc.2.40%244,315
5NKTRNektar Therapeutics2.31%100,451
6AXSMAxsome Therapeutics, Inc.2.30%38,859
7MRKMerck & Co., Inc.2.29%59,415
8AMRXAmneal Pharmaceuticals, Inc.2.25%475,024
9LQDALiquidia Corporation2.24%177,480
10PAHCPhibro Animal Health Corporation2.24%134,921
11JNJJohnson & Johnson2.22%28,082
12RPRXRoyalty Pharma plc2.20%151,596
13BMYBristol-Myers Squibb Company2.19%113,260
14ELANElanco Animal Health Incorporated2.18%272,303
15PBHPrestige Consumer Healthcare Inc.2.05%94,525
16INVAInnoviva, Inc.2.04%281,283
17SUPNSupernus Pharmaceuticals, Inc.2.02%125,651
18PFEPfizer Inc.2.00%224,982
19ZTSZoetis Inc.1.99%49,124
20PRGOPerrigo Company plc1.99%428,997
21AMLXAmylyx Pharmaceuticals, Inc.1.99%438,401
22MAZEMaze Therapeutics, Inc.1.98%130,094
23LLYEli Lilly and Company1.96%5,837
24ELVNEnliven Therapeutics, Inc.1.92%218,762
25JAZZJazz Pharmaceuticals plc1.89%35,158
Showing 25 of 59 holdings
Subscribe to see the full list
As of Feb 12, 2026